Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2811316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Yelin Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ward 3 of Cardiovascular Medicine, Qingdao Hospital of Traditional Chinese Medicine, 266033 Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Apoptosis, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Education Fund of Shandong Province, Introduction and Training team of Outstanding Young Talents of Shandong Province "Clinical Teaching Reform and Inn….
Abstract (Originalsprache)
Background
Copine 1 (CPNE1) acts as a promoter in the progression of many kinds of cancers with the exception of pancreatic cancer (PC). This research is designed to probe the function of the CPNE1-tumor necrosis factor receptor-associated factor 2 (TRAF2) axis in PC.
Methods
In vivo and in vitro models of PC were constructed, and a series of biological function tests, including MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], colony formation, flow cytometry, and immunohistochemistry, were performed.
Results
The level of CPNE1 elevated dramatically in PC cells. Downregulation of CPNE1in PC cells resulted in the inhibition of colony formation and proliferation. In addition, the silencing of CPNE1 induced the G1/S arrest and apoptosis in PC cells. Additionally, TRAF2 positively interacted with CPNE1 in PANC cells. CPNE1 silencing also inhibited the growth of tumors in in vivo mouse models. Functional experiments revealed that the anti-tumor effect of CPNE1 silencing was counteracted by TRAF2 overexpression, and the tumor-promoting effect of TRAF2 overexpression was reversed by CPNE1 silencing.
Conclusions
In summary, our findings indicate that the silencing of the CPNE1-TRAF2 axis restrains PC development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ward 3 of Cardiovascular Medicine, Qingdao Hospital of Traditional Chinese Medicine, 266033 Qingdao, Shandong, China.
- Department of General Surgery, People's Hospital of Chengyang, 266109 Qingdao, Shandong, China.
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250355 Jinan, Shandong, China.
- Qingdao Medical College, Qingdao University, 266073 Qingdao, Shandong, China.
- The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, 250014 Jinan, Shandong, China.
- Encephalopathy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 250000 Jinan, Shandong, China.
Förderung
- Special Education Fund of Shandong Province, Introduction and Training team of Outstanding Young Talents of Shandong Province "Clinical Teaching Reform and Inn…
Zitieren
APA
Song, Y., Song, B., Yu, Z., Li, A., Xia, L., Zhao, Y., Lu, Z., & Li, Z. (2023). Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2811316
Vancouver
Song Y, Song B, Yu Z, Li A, Xia L, Zhao Y, et al. Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2811316
BibTeX
@article{Song2023,
author = {Song, Yelin and Song, Baolian and Yu, Zhichao and Li, Andong and Xia, Lulu and Zhao, Yanwen and Lu, Zhongwen and Li, Zuowei},
title = {Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2811316}
}
EUVIMED